Resignation of Director

NZX Announcement 1 April 2020 Resignation of Director Truscreen Limited ("the Company") announces that prominent New Zealand gynaecologist, Dr. Ron Jones has retired from the board of the Company as at 31 March 2020. Dr. Jones has also stepped down from the Company's Medical Advisory Board ("MAC"). The board of the Company will be reduced to four directors. The MAC will also be reduced to a committee of two members. Dr. Jones joined the board as a non-executive director on 19 October 2017 and provided counsel to the Company on the development of and successful commercialisation of the Company's Truscreen T2 cervical cancer screening device. He also provided an important link between the board and the MAC in relation to the MAC's development of clinical trial protocols and analysis of clinical trial results. Dr. Jones was an early key contributor of cervical cancer screening trial results from Auckland Hospital that significantly added to the benchmark datasets on which the Truscreen technology was developed. On behalf of the board, the Truscreen team and fellow members of the MAC, we thank Dr. Jones for his contributions to Truscreen and extend our best wishes for all his future endeavours in his retirement. Tony Ho Chairman - ENDS - For more information, visit www.truscreen.com or contact: TruScreen Tony Ho Chairman tonyho@truscreen.com End CA:00351073 For:TRU Type:ADMIN Time:2020-04-01 11:37:07